Determination of the Degree of Esterification in Heparin Benzylates During Synthesis of Enoxaparin, a Domestic Analog of Low-Molecular-Mass Heparin


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

The esterification stage of low-molecular-mass heparin (enoxaparin) production by hydrolytic depolymerization of unfractionated heparin was studied and consisted of treating previously synthesized benzethonium heparinate with benzyl chloride. The content of benzyl moieties in the synthesized heparin benzylates and their degree of benzylation were determined using HPLC, PMR, and 13C NMR methods. A carboxylic-acid content of 0.13 ± 0.01 mol/g in the starting heparin was calculated from these results. A new method for estimating the degree of heparin benzylation from PMR and HPLC data was proposed. The benzyl content in the heparin benzylates increased with increasing molar excess of benzyl chloride.

Об авторах

L. Frumin

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454

K. Yur’eva

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Автор, ответственный за переписку.
Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454

A. Matveev

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454

E. Vorfolomeeva

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

I. Vostrov

Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Россия, Skolkovo, Moscow, 121353

G. Zatonskii

G. F. Gause Institute of New Antibiotics

Email: kristina.yureva1994@mail.ru
Россия, 11 Bol’shaya Pirogovskaya St., Moscow, 119435

D. Prokhorov

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454

E. Zhavoronok

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

A. Panov

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

L. Grebenkina

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454

N. Pyatigorskaya

I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: kristina.yureva1994@mail.ru
Россия, Moscow

G. Brkich

I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: kristina.yureva1994@mail.ru
Россия, Moscow

S. Kedik

M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies

Email: kristina.yureva1994@mail.ru
Россия, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2019

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).